MétaCan
Menu
Back to cohort
Record W2899190657 · doi:10.3747/co.25.4003

Survival Outcome Differences Based on Treatments Used and Knowledge of the Primary Tumour Site for Patients with Cancer of Unknown and Known Primary in Ontario

2018· article· en· W2899190657 on OpenAlexafffundvenueabout
C.S. Kim, Malek B. Hannouf, Sisira Sarma, George Rodrigues, Peter K. Rogan, Salaheddin M. Mahmud, Eric Winquist, Muriel Brackstone, Gregory S. Zaric

Bibliographic record

VenueCurrent Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicCancer Diagnosis and Treatment
Canadian institutionsManitoba HealthUniversity of ManitobaCancer Care OntarioWestern University
FundersCanadian Institutes of Health ResearchAmgenCancer Care OntarioSanofi PasteurOntario Ministry of Health and Long-Term CareOntario Institute for Cancer ResearchAstraZeneca
KeywordsMedicineCancerCancer registryProportional hazards modelInternal medicinePrimary tumorCohortRadiation therapyChemotherapyPrimary cancerOncologySurgeryMetastasis

Abstract

fetched live from OpenAlex

Introduction: Patients with cancer of unknown primary (CUP) have pathologically confirmed metastatic tumours with unidentifiable primary tumours. Currently, very little is known about the relationship between the treatment of patients with CUP and their survival outcomes. Thus, we compared oncologic treatment and survival outcomes for patients in Ontario with CUP against those for a cohort of patients with metastatic cancer of known primary site. Methods: Using the Ontario Cancer Registry and the Same-Day Surgery and Discharge Abstract databases maintained by the Canadian Institute for Health Information, we identified all Ontario patients diagnosed with metastatic cancer between 1 January 2000 and 31 December 2005. Ontario Health Insurance Plan treatment records were linked to identify codes for surgery, chemotherapy, or therapeutic radiation related to oncology. Multivariable Cox regression models were constructed, adjusting for histology, age, sex, and comorbidities. Results: In 45,347 patients (96.3%), the primary tumour site was identifiable, and in 1743 patients (3.7%), CUP was diagnosed. Among the main tumour sites, CUP ranked as the 6th largest. The mean Charlson score was significantly higher (p < 0.0001) in patients with CUP (1.88) than in those with a known primary (1.42). Overall median survival was 1.9 months for patients with CUP compared with 11.9 months for all patients with a known-primary cancer. Receipt of treatment was more likely for patients with a known primary site (n = 35,012, 77.2%) than for those with CUP (n = 891, 51.1%). Among patients with a known primary site, median survival was significantly higher for treated than for untreated patients (19.0 months vs. 2.2 months, p < 0.0001). Among patients with CUP, median survival was also higher for treated than for untreated patients (3.6 months vs. 1.1 months, p < 0.0001). Conclusions: In Ontario, patients with CUP experience significantly lower survival than do patients with metastatic cancer of a known primary site. Treatment is associated with significantly increased survival both for patients with CUP and for those with metastatic cancer of a known primary site.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.228
Threshold uncertainty score0.459

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.082
GPT teacher head0.365
Teacher spread0.283 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2018
Admission routes4
Has abstractyes

Explore more

Same venueCurrent OncologySame topicCancer Diagnosis and TreatmentFrench-language works237,207